Showing results (141-150 of 193) with videos related to
Sort By:
Pageof 20
Breast Cancer Research and Treatment|October 17, 2014
Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective studyJ Jacob, L Belin, J Y Pierga, et al.Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.Breast (Edinburgh, Scotland)|September 30, 2004
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of ageJ-Y Pierga, V Girre, V Laurence, et al.Cancer|December 1, 1991
Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breastL J Solin, A Recht, A Fourquet, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6S M Scholl, A Fourquet, B Asselain, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 11, 2011
Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodesC E de Almeida, N Fournier-Bidoz, C Massabeau, et al.Cancer|April 15, 1993
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatmentL J Solin, I T Yeh, J Kurtz, et al.European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Preoperative breast radiation therapy: Indications and perspectivesS V Lightowlers, L J Boersma, A Fourquet, et al.Lancet (London, England)|April 24, 1993
Age as prognostic factor in premenopausal breast carcinomaA de la Rochefordiere, B Asselain, F Campana, et al.Bulletin Du Cancer|October 13, 2009
[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]L Willems, F Suarez, E Messas, et al.Pageof 20